Read More General business news Can Illumina’s SomaLogic takeover finally make multiomics scalable at pharma speed? Illumina has acquired SomaLogic to deepen its proteomics and multiomics capabilities. Find out what this means for genomics, pharma, and platform rivals. byPallavi MadhirajuFebruary 2, 2026